International developed-market equities remain a core allocation for investors seeking diversification beyond U.S. stocks. IEFA and JIRE target the same broad MSCI EAFE universe, but they do so through fundamentally different approaches. One is a low-cost, market-cap-weighted index fund; the other is an actively managed strategy designed to outperform that index. Comparing the two helps investors weigh pure, broad beta against concentrated, research-driven exposure — a decision that has meaningful implications for cost, diversification, and risk. I also checked sector overlaps using Tickeron’s AI tools to confirm the shared emphasis on financials and industrials.
IEFA is a passively managed exchange-traded fund that tracks the MSCI EAFE Investable Market Index (IMI), which covers developed markets outside the U.S. and Canada across Europe, Australasia, and the Far East. The fund holds roughly 2,600 securities spanning large-, mid-, and small-capitalization companies, making it one of the broadest and most liquid international equity vehicles available.
Its largest positions include ASML Holding, HSBC Holdings, Roche, Shell, Novartis, AstraZeneca, Nestlé, SAP, Mitsubishi UFJ Financial Group, and Siemens. Sector allocation is dominated by financial services (roughly 23%), industrials (about 17–19%), technology (roughly 11–12%), and healthcare (about 10%). Geographically, Japan is the largest country weight at roughly 24–25%, followed by the United Kingdom, France, Germany, and Switzerland.
The fund charges an expense ratio of just 0.07%, reflecting its index-replication mandate and optimized sampling methodology. This low cost, combined with deep diversification and substantial assets under management (AUM), gives IEFA a strong structural foundation as a core international holding. A quick scan with Tickeron’s AI Screener highlighted its scale relative to peers in the category.
JIRE is an actively managed ETF that seeks long-term capital appreciation by outperforming the MSCI EAFE Index while maintaining similar sector and geographic risk characteristics. The strategy invests at least 80% of its assets in equity securities of developed-market companies, primarily drawn from the EAFE benchmark universe but with latitude to hold names outside it.
The fund is far more concentrated than IEFA, holding roughly 220 stocks, with the top ten positions representing a meaningful share of the portfolio. Top holdings include ASML Holding, AstraZeneca, Shell, Banco Santander, Siemens, Allianz, Nestlé, Roche, and Barclays. Sector exposure mirrors the benchmark, led by financial services (about 26%), industrials (roughly 19%), technology (about 11%), and healthcare (about 10%). Japan is the largest country allocation at roughly 22%, followed by the United Kingdom, France, Germany, and Switzerland.
JIRE carries a net expense ratio of 0.24% (0.29% gross). Although the underlying strategy dates to 1992, its current ETF structure launched in 2022. The fund relies on J.P. Morgan's fundamental research and portfolio managers to select securities, introducing active risk in pursuit of benchmark-beating returns. I cross-checked its holdings concentration against similar active strategies via Tickeron’s AI Daily Buy/Sell Signals for context.
Both funds operate in the foreign large-blend segment of developed international markets, a category shaped by several durable forces. Currency movements, particularly the strength of the U.S. dollar versus the euro, yen, and pound, materially influence returns for U.S.-based investors. Interest-rate trajectories across the Bank of Japan, European Central Bank, and Bank of England affect the financial-heavy composition both ETFs share, as banks benefit from or are pressured by changing yield curves.
The European and Japanese semiconductor and industrial sectors — represented by holdings such as ASML and Siemens — remain sensitive to global technology and capital-spending cycles. Meanwhile, energy and materials exposure ties both funds to commodity price trends. Capital flows into international equities have fluctuated with relative U.S. valuations, and regulatory developments in European banking and healthcare add another layer of sector-specific risk. These macro drivers affect IEFA and JIRE alike, though JIRE's concentrated portfolio can amplify the impact of individual positions.
Over recent weeks and market cycles, both ETFs have moved broadly in line with developed international equities, reflecting their shared EAFE-based exposure. IEFA's performance is essentially the benchmark minus its minimal 0.07% fee, giving it a predictable, low-tracking-error profile. JIRE, by contrast, has shown the capacity for modest relative outperformance during periods when its active overweight positions — historically including select financial, healthcare, and technology names — have led the market, though this comes with wider dispersion around the benchmark.
Relative positioning differs by concentration and volatility. IEFA spreads risk across thousands of holdings, while JIRE's roughly 220 names mean a handful of stock decisions can sway results. During sector rotations favoring financials and industrials, both funds benefit, but JIRE's higher weights can magnify gains or losses. IEFA's lower cost and broader diversification provide a steadier, more predictable relative path, whereas JIRE offers the possibility — but not the guarantee — of alpha through active management.
When comparing these ETFs, I used Tickeron’s AI Screener to filter for similar international funds and assess their relative metrics. It’s a useful way to quickly scan technical patterns and fundamentals across thousands of securities, helping identify trade ideas and market opportunities more efficiently than manual screening. Explore the AI Screener to refine your ETF comparison and uncover relative positioning signals.
Based on observable structural factors, Tickeron's AI would likely favor IEFA over JIRE in this comparison. IEFA's 0.07% expense ratio offers a substantial cost advantage over JIRE's 0.24% fee, and its roughly 2,600-holding portfolio provides dramatically broader diversification with minimal single-stock or manager risk. While JIRE's active strategy has the potential to outperform, that outcome is not guaranteed and carries concentration and active-management risk. IEFA's consistent index tracking, deep liquidity, and low cost give it a more durable, probability-weighted structural edge for long-term international equity exposure.
The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.
Sergey Savastiouk, Ph.D. has a degree in Applied Mathematics from Moscow University and has extensive experience as an entrepreneur, investor, manager, and mathematician. His professional expertise is in applied mathematics, mathematical modeling, system and pattern analysis, and software and hardware system integration. He has served as the CEO of several hi-tech start-up companies and nonprofit organizations, which has given him proven capabilities in business strategy for high-tech start-up companies, market assessment, company formation, team building, product development, marketing, and sales. He has published numerous articles in journals and magazines on related fields. As a retail investor, he spent 15 years developing his proprietary trading and quantitative algorithms (now Tickeron’s A.I.), which brought him significant returns in trading the stock market. His current work and goal in founding Tickeron is to bring professional, sophisticated stock market analysis capabilities to retail investors via an easy-to-use interface.
IEFA saw its Moving Average Convergence Divergence Histogram (MACD) turn negative on November 17, 2026. This is a bearish signal that suggests the stock could decline going forward. Tickeron's A.I.dvisor looked at 46 instances where the indicator turned negative. In 39 of the 46 cases the stock moved lower in the days that followed. This puts the odds of a downward move at 85%.
The Momentum Indicator moved below the 0 level on November 16, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on IEFA as a result. In 62 of 79 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are 78%.
IEFA moved below its 50-day moving average on November 10, 2026 date and that indicates a change from an upward trend to a downward trend.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where IEFA declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 77%.
The Aroon Indicator for IEFA entered a downward trend on November 03, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.
The RSI Indicator demonstrates that the ticker has stayed in the oversold zone for 1 day, which means it's wise to expect a price bounce in the near future.
The Stochastic Oscillator demonstrated that the ticker has stayed in the oversold zone for 2 days, which means it's wise to expect a price bounce in the near future.
Following a +0.63% 3-day Advance, the price is estimated to grow further. Considering data from situations where IEFA advanced for three days, in 264 of 320 cases, the price rose further within the following month. The odds of a continued upward trend are 82%.
IEFA may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.
The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows